BridgeBio Oncology Therapeutics, Inc. (BBOT) Misses Q2 EPS by 70468c
Tweet
Share
E-mailGet Alerts BBOT Hot Sheet
Join SI Premium – FREE
BridgeBio Oncology Therapeutics, Inc. (NASDAQ: BBOT) reported Q2 EPS of ($705.20), $704.68 worse than the analyst estimate of ($0.52).
For earnings history and earnings-related data on BridgeBio Oncology Therapeutics, Inc. (BBOT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Increasing unusual put volume: CAPR BW AEP NMAX KORU VCX SM YSS HWM MUU WDAY NU
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
